238 related articles for article (PubMed ID: 29615438)
1. Generation of Intestinal Organoids Suitable for Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells.
Onozato D; Yamashita M; Nakanishi A; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Nov; 46(11):1572-1580. PubMed ID: 29615438
[TBL] [Abstract][Full Text] [Related]
2. Efficient Generation of Cynomolgus Monkey Induced Pluripotent Stem Cell-Derived Intestinal Organoids with Pharmacokinetic Functions.
Onozato D; Yamashita M; Fukuyama R; Akagawa T; Kida Y; Koeda A; Hashita T; Iwao T; Matsunaga T
Stem Cells Dev; 2018 Aug; 27(15):1033-1045. PubMed ID: 29742964
[TBL] [Abstract][Full Text] [Related]
3. Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds.
Iwao T; Kodama N; Kondo Y; Kabeya T; Nakamura K; Horikawa T; Niwa T; Kurose K; Matsunaga T
Drug Metab Dispos; 2015 Apr; 43(4):603-10. PubMed ID: 25650381
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mitogen-activated protein kinase kinase, DNA methyltransferase, and transforming growth factor-β promotes differentiation of human induced pluripotent stem cells into enterocytes.
Kodama N; Iwao T; Kabeya T; Horikawa T; Niwa T; Kondo Y; Nakamura K; Matsunaga T
Drug Metab Pharmacokinet; 2016 Jun; 31(3):193-200. PubMed ID: 27161454
[TBL] [Abstract][Full Text] [Related]
5. Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
Kodama N; Iwao T; Katano T; Ohta K; Yuasa H; Matsunaga T
Drug Metab Dispos; 2016 Oct; 44(10):0. PubMed ID: 27417181
[TBL] [Abstract][Full Text] [Related]
6. [Development of an In Vitro System for Evaluating Intestinal Drug Disposition Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells].
Iwao T
Yakugaku Zasshi; 2018; 138(10):1241-1247. PubMed ID: 30270266
[TBL] [Abstract][Full Text] [Related]
7. [Utilization of Human iPS Cells for Evaluation of Drug Disposition and Mucosal Damages in the Small Intestine].
Iwao T
Yakugaku Zasshi; 2023; 143(3):243-247. PubMed ID: 36858557
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cells.
Janssen AWF; Duivenvoorde LPM; Rijkers D; Nijssen R; Peijnenburg AACM; van der Zande M; Louisse J
Arch Toxicol; 2021 Mar; 95(3):907-922. PubMed ID: 33263786
[TBL] [Abstract][Full Text] [Related]
9. A xenogeneic-free system generating functional human gut organoids from pluripotent stem cells.
Uchida H; Machida M; Miura T; Kawasaki T; Okazaki T; Sasaki K; Sakamoto S; Ohuchi N; Kasahara M; Umezawa A; Akutsu H
JCI Insight; 2017 Jan; 2(1):e86492. PubMed ID: 28097227
[TBL] [Abstract][Full Text] [Related]
10. Nutrient sensing by absorptive and secretory progenies of small intestinal stem cells.
Kishida K; Pearce SC; Yu S; Gao N; Ferraris RP
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G592-G605. PubMed ID: 28336548
[TBL] [Abstract][Full Text] [Related]
11. Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research.
Inui T; Uraya Y; Yokota J; Yamashita T; Kawai K; Okada K; Ueyama-Toba Y; Mizuguchi H
Stem Cell Res Ther; 2024 Feb; 15(1):57. PubMed ID: 38424603
[TBL] [Abstract][Full Text] [Related]
12. Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule Therapeutics.
Sawant-Basak A; Rodrigues AD; Lech M; Doyonnas R; Kasaian M; Prasad B; Tsamandouras N
Drug Metab Dispos; 2018 Nov; 46(11):1581-1587. PubMed ID: 30126862
[TBL] [Abstract][Full Text] [Related]
13. Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells.
Naumovska E; Aalderink G; Wong Valencia C; Kosim K; Nicolas A; Brown S; Vulto P; Erdmann KS; Kurek D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674311
[TBL] [Abstract][Full Text] [Related]
14. Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells.
Negoro R; Takayama K; Nagamoto Y; Sakurai F; Tachibana M; Mizuguchi H
Biochem Biophys Res Commun; 2016 Apr; 472(4):631-6. PubMed ID: 26966071
[TBL] [Abstract][Full Text] [Related]
15. Generation of intestinal organoids derived from human pluripotent stem cells for drug testing.
Yoshida S; Miwa H; Kawachi T; Kume S; Takahashi K
Sci Rep; 2020 Apr; 10(1):5989. PubMed ID: 32249832
[TBL] [Abstract][Full Text] [Related]
16. Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells.
Onozato D; Ogawa I; Kida Y; Mizuno S; Hashita T; Iwao T; Matsunaga T
J Pharm Sci; 2021 Jul; 110(7):2637-2650. PubMed ID: 33794275
[TBL] [Abstract][Full Text] [Related]
17.
Jung KB; Lee H; Son YS; Lee JH; Cho HS; Lee MO; Oh JH; Lee J; Kim S; Jung CR; Kim J; Son MY
FASEB J; 2018 Jan; 32(1):111-122. PubMed ID: 28855280
[TBL] [Abstract][Full Text] [Related]
18. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells.
Kabeya T; Qiu S; Hibino M; Nagasaki M; Kodama N; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Oct; 46(10):1411-1419. PubMed ID: 30068521
[TBL] [Abstract][Full Text] [Related]
20. Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction.
Takayama K; Negoro R; Yamashita T; Kawai K; Ichikawa M; Mori T; Nakatsu N; Harada K; Ito S; Yamada H; Yamaura Y; Hirata K; Ishida S; Mizuguchi H
Cell Mol Gastroenterol Hepatol; 2019; 8(3):513-526. PubMed ID: 31228606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
